Showing results (1811-1820 of 1,875) with videos related to

Sort By:
Pageof 188
Practical Radiation Oncology|April 19, 2019
Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology PatientsHiram A Gay, Roberto Santiago, Betty Gil, et al.
Arthritis Care & Research|April 17, 2012
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized sclerodermaSuzanne C Li, Kathryn S Torok, Elena Pope, et al.
The American Journal of Tropical Medicine and Hygiene|January 24, 2020
A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool, Peter Billingsley, Fred Binka, et al.
Eclinicalmedicine|July 28, 2026
Risk of adverse pregnancy outcomes following inadvertent exposure to ivermectin during the periconception period: findings from two cluster-randomized trials in Mozambique and KenyaPatricia Nicolas, Hansel Mundaca, Aurelia Brazeal, et al.
Nature Cancer|February 5, 2022
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitorsRom Keshet, Joo Sang Lee, Lital Adler, et al.
Endocrinologia, Diabetes Y Nutricion|February 19, 2019
ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegalyCristina Álvarez-Escolá, Eva María Venegas-Moreno, Juan Antonio García-Arnés, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and EnthesitisSarah Ringold, Sheila T Angeles-Han, Timothy Beukelman, et al.
Journal of Thrombosis and Haemostasis : JTH|December 16, 2014
Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndromeA Rabinovich, J M Cohen, M Cushman, et al.
Blood Advances|August 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphomaXavier Deschênes-Simard, Maria Bromberg, Sean M Devlin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.
Pageof 188